PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HMCX.L vs. UBS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between HMCX.L and UBS is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

HMCX.L vs. UBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HSBC FTSE 250 UCITS ETF GBP (HMCX.L) and UBS Group AG (UBS). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
-1.69%
7.35%
HMCX.L
UBS

Key characteristics

Sharpe Ratio

HMCX.L:

1.15

UBS:

0.94

Sortino Ratio

HMCX.L:

1.66

UBS:

1.38

Omega Ratio

HMCX.L:

1.21

UBS:

1.19

Calmar Ratio

HMCX.L:

0.81

UBS:

1.64

Martin Ratio

HMCX.L:

5.14

UBS:

4.35

Ulcer Index

HMCX.L:

2.66%

UBS:

5.54%

Daily Std Dev

HMCX.L:

11.94%

UBS:

25.75%

Max Drawdown

HMCX.L:

-41.50%

UBS:

-59.82%

Current Drawdown

HMCX.L:

-6.04%

UBS:

-7.32%

Returns By Period

In the year-to-date period, HMCX.L achieves a 1.73% return, which is significantly lower than UBS's 9.37% return. Over the past 10 years, HMCX.L has underperformed UBS with an annualized return of 4.55%, while UBS has yielded a comparatively higher 12.50% annualized return.


HMCX.L

YTD

1.73%

1M

6.29%

6M

2.08%

1Y

11.94%

5Y*

1.51%

10Y*

4.55%

UBS

YTD

9.37%

1M

2.63%

6M

13.37%

1Y

23.49%

5Y*

26.64%

10Y*

12.50%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HMCX.L vs. UBS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HMCX.L
The Risk-Adjusted Performance Rank of HMCX.L is 4444
Overall Rank
The Sharpe Ratio Rank of HMCX.L is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of HMCX.L is 4646
Sortino Ratio Rank
The Omega Ratio Rank of HMCX.L is 4545
Omega Ratio Rank
The Calmar Ratio Rank of HMCX.L is 3535
Calmar Ratio Rank
The Martin Ratio Rank of HMCX.L is 4949
Martin Ratio Rank

UBS
The Risk-Adjusted Performance Rank of UBS is 7575
Overall Rank
The Sharpe Ratio Rank of UBS is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of UBS is 6767
Sortino Ratio Rank
The Omega Ratio Rank of UBS is 6767
Omega Ratio Rank
The Calmar Ratio Rank of UBS is 8787
Calmar Ratio Rank
The Martin Ratio Rank of UBS is 7878
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HMCX.L vs. UBS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HSBC FTSE 250 UCITS ETF GBP (HMCX.L) and UBS Group AG (UBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HMCX.L, currently valued at 0.73, compared to the broader market0.002.004.000.730.97
The chart of Sortino ratio for HMCX.L, currently valued at 1.09, compared to the broader market0.005.0010.001.091.43
The chart of Omega ratio for HMCX.L, currently valued at 1.13, compared to the broader market0.501.001.502.002.503.001.131.19
The chart of Calmar ratio for HMCX.L, currently valued at 0.44, compared to the broader market0.005.0010.0015.0020.000.441.68
The chart of Martin ratio for HMCX.L, currently valued at 2.03, compared to the broader market0.0020.0040.0060.0080.00100.00120.002.034.44
HMCX.L
UBS

The current HMCX.L Sharpe Ratio is 1.15, which is comparable to the UBS Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of HMCX.L and UBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
0.73
0.97
HMCX.L
UBS

Dividends

HMCX.L vs. UBS - Dividend Comparison

HMCX.L's dividend yield for the trailing twelve months is around 3.00%, less than UBS's 3.17% yield.


TTM20242023202220212020201920182017201620152014
HMCX.L
HSBC FTSE 250 UCITS ETF GBP
3.00%3.10%2.99%2.73%2.02%1.76%2.53%3.19%2.60%3.36%2.77%2.51%
UBS
UBS Group AG
3.17%3.46%1.78%2.68%2.07%10.34%5.48%5.24%3.30%9.41%4.11%0.00%

Drawdowns

HMCX.L vs. UBS - Drawdown Comparison

The maximum HMCX.L drawdown since its inception was -41.50%, smaller than the maximum UBS drawdown of -59.82%. Use the drawdown chart below to compare losses from any high point for HMCX.L and UBS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-15.50%
-7.32%
HMCX.L
UBS

Volatility

HMCX.L vs. UBS - Volatility Comparison

The current volatility for HSBC FTSE 250 UCITS ETF GBP (HMCX.L) is 3.65%, while UBS Group AG (UBS) has a volatility of 9.90%. This indicates that HMCX.L experiences smaller price fluctuations and is considered to be less risky than UBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February
3.65%
9.90%
HMCX.L
UBS
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab